ONCY logo

ONCY
Oncolytics Biotech, Inc.

7,533
Mkt Cap
$101.94M
Volume
391,793.00
52W High
$1.51
52W Low
$0.3258
PE Ratio
-3.37
ONCY Fundamentals
Price
$0.9235
Prev Close
$0.9473
Open
$0.934
50D MA
$1.01
Beta
0.86
Avg. Volume
1.97M
EPS (Annual)
-$0.3026
P/B
1,184.13
Rev/Employee
$0.00
$59.55
Loading...
Loading...
News
all
press releases
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care PR Newswire VANCOUVER, BC, March 19, 2026...
PR Newswire·5d ago
News Placeholder
More News
News Placeholder
James Parsons Acquires 10,000 Shares of Oncolytics Biotech (NASDAQ:ONCY) Stock
Oncolytics Biotech Inc. (NASDAQ:ONCY - Get Free Report) Director James Parsons acquired 10,000 shares of the firm's stock in a transaction dated Wednesday, March 11th. The stock was bought at an...
MarketBeat·10d ago
News Placeholder
Insider Buying: Oncolytics Biotech (NASDAQ:ONCY) Director Purchases 10,000 Shares of Stock
Oncolytics Biotech Inc. (NASDAQ:ONCY - Get Free Report) Director James Parsons acquired 10,000 shares of Oncolytics Biotech stock in a transaction that occurred on Wednesday, March 11th. The stock...
MarketBeat·11d ago
News Placeholder
Oncolytics Biotech Inc. (NASDAQ:ONCY) Receives Average Rating of "Moderate Buy" from Brokerages
Oncolytics Biotech Inc. (NASDAQ:ONCY - Get Free Report) has earned an average recommendation of "Moderate Buy" from the five research firms that are currently covering the firm, MarketBeat.com...
MarketBeat·13d ago
News Placeholder
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types PR Newswire VANCOUVER...
PR Newswire·19d ago
News Placeholder
Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion
Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion PR Newswire VANCOUVER, BC, March 3, 2026...
PR Newswire·21d ago
News Placeholder
Oncolytics Biotech (ONCY) Expected to Announce Earnings on Friday
Oncolytics Biotech (NASDAQ:ONCY) will be releasing its Q4 2025 earnings before the market opens on Friday, March 6. (View Earnings Report at...
MarketBeat·26d ago
News Placeholder
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 PR Newswire VANCOUVER, BC, Feb. 25, 2026...
PR Newswire·27d ago
News Placeholder
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge PR Newswire VANCOUVER, BC, Feb. 24...
PR Newswire·28d ago
News Placeholder
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else New Treatment Modalities Are Reaching Cancers That Resisted Everything Else PR Newswire VANCOUVER, BC, Feb. 17, 2026 Issued...
PR Newswire·1mo ago
<
1
2
...
>

Latest ONCY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.